title: Gain of Olig2 function in oligodendrocyte progenitors promotes remyelination.
abstract: The basic helix-loop-helix transcription factor Olig2 is a key determinant for the specification of neural precursor cells into oligodendrocyte progenitor cells. However, the functional role of Olig2 in oligodendrocyte migration and differentiation remains elusive both during developmental myelination and under demyelinating conditions of the adult central nervous system. To decipher Olig2 functions, we generated transgenic mice (TetOlig2:Sox10(rtTA/+)) overexpressing Olig2 in Sox10(+) oligodendroglial cells in a doxycycline inducible manner. We show that Olig2 overexpression increases the generation of differentiated oligodendrocytes, leading to precocious myelination of the central nervous system. Unexpectedly, we found that gain of Olig2 function in oligodendrocyte progenitor cells enhances their migration rate. To determine whether Olig2 overexpression in adult oligodendrocyte progenitor cells promotes oligodendrocyte regeneration for myelin repair, we induced lysophosphatidylcholine demyelination in the corpus callosum of TetOlig2:Sox10(rtTA/+) and control mice. We found that Olig2 overexpression enhanced oligodendrocyte progenitor cell differentiation and remyelination. To assess the relevance of these findings in demyelinating diseases, we also examined OLIG2 expression in multiple sclerosis lesions. We demonstrate that OLIG2 displays a differential expression pattern in multiple sclerosis lesions that correlates with lesion activity. Strikingly, OLIG2 was predominantly detected in NOGO-A(+) (now known as RTN4-A) maturing oligodendrocytes, which prevailed in active lesion borders, rather than chronic silent and shadow plaques. Taken together, our data provide proof of principle indicating that OLIG2 overexpression in oligodendrocyte progenitor cells might be a possible therapeutic mechanism for enhancing myelin repair.
authors.affiliation: 1 Inserm, U 1127, F-75013, Paris, France 1 Inserm, U 1127, F-75013, Paris, France 1 Inserm, U 1127, F-75013, Paris, France 1 Inserm, U 1127, F-75013, Paris, France 1 Inserm, U 1127, F-75013, Paris, France.
authors.forename: Amélie
authors.initials: A
authors.lastname: Wegener
authors.affiliation: 1 Inserm, U 1127, F-75013, Paris, France 1 Inserm, U 1127, F-75013, Paris, France 1 Inserm, U 1127, F-75013, Paris, France 1 Inserm, U 1127, F-75013, Paris, France.
authors.forename: Cyrille
authors.initials: C
authors.lastname: Deboux
authors.affiliation: 1 Inserm, U 1127, F-75013, Paris, France 1 Inserm, U 1127, F-75013, Paris, France 1 Inserm, U 1127, F-75013, Paris, France 1 Inserm, U 1127, F-75013, Paris, France.
authors.forename: Corinne
authors.initials: C
authors.lastname: Bachelin
authors.affiliation: 1 Inserm, U 1127, F-75013, Paris, France 1 Inserm, U 1127, F-75013, Paris, France 1 Inserm, U 1127, F-75013, Paris, France 1 Inserm, U 1127, F-75013, Paris, France.
authors.forename: Magali
authors.initials: M
authors.lastname: Frah
authors.affiliation: 1 Inserm, U 1127, F-75013, Paris, France 1 Inserm, U 1127, F-75013, Paris, France 1 Inserm, U 1127, F-75013, Paris, France 1 Inserm, U 1127, F-75013, Paris, France.
authors.forename: Christophe
authors.initials: C
authors.lastname: Kerninon
authors.affiliation: 1 Inserm, U 1127, F-75013, Paris, France 1 Inserm, U 1127, F-75013, Paris, France 1 Inserm, U 1127, F-75013, Paris, France 1 Inserm, U 1127, F-75013, Paris, France 1 Inserm, U 1127, F-75013, Paris, France.
authors.forename: Danielle
authors.initials: D
authors.lastname: Seilhean
authors.affiliation: 1 Inserm, U 1127, F-75013, Paris, France.
authors.forename: Matthias
authors.initials: M
authors.lastname: Weider
authors.affiliation: 1 Inserm, U 1127, F-75013, Paris, France.
authors.forename: Michael
authors.initials: M
authors.lastname: Wegner
authors.affiliation: 1 Inserm, U 1127, F-75013, Paris, France 1 Inserm, U 1127, F-75013, Paris, France 1 Inserm, U 1127, F-75013, Paris, France 1 Inserm, U 1127, F-75013, Paris, France 1 Inserm, U 1127, F-75013, Paris, France brahim.nait_oumesmar@upmc.fr.
authors.forename: Brahim
authors.initials: B
authors.lastname: Nait-Oumesmar
mesh_terms: D000818:Animals; D000831:Animals, Newborn; D051792:Basic Helix-Loop-Helix Proteins / Q000235:genetics / Q000378:metabolism*; D002454:Cell Differentiation / Q000235:genetics; D002478:Cells, Cultured; D003711:Demyelinating Diseases / Q000139:chemically induced / Q000378:metabolism* / Q000473:pathology; D004195:Disease Models, Animal; D004318:Doxycycline / Q000494:pharmacology; D004622:Embryo, Mammalian; D005786:Gene Expression Regulation / Q000235:genetics; D008244:Lysophosphatidylcholines / Q000633:toxicity; D051379:Mice; D008810:Mice, Inbred C57BL; D008822:Mice, Transgenic; D009103:Multiple Sclerosis / Q000473:pathology; D009186:Myelin Sheath / Q000502:physiology*; D009419:Nerve Tissue Proteins / Q000235:genetics / Q000378:metabolism*; D000076104:Oligodendrocyte Transcription Factor 2; D009836:Oligodendroglia / Q000473:pathology / Q000502:physiology* / Q000648:ultrastructure; D012038:Regeneration / Q000187:drug effects / Q000235:genetics*; D055757:SOXE Transcription Factors / Q000235:genetics / Q000378:metabolism; D013116:Spinal Cord / Q000166:cytology* / Q000473:pathology; D013234:Stem Cells / Q000502:physiology*
chemical_list: D051792:Basic Helix-Loop-Helix Proteins; D004318:Doxycycline; D008244:Lysophosphatidylcholines; D009419:Nerve Tissue Proteins; D000076104:Oligodendrocyte Transcription Factor 2; D055757:SOXE Transcription Factors; C512773:Olig2 protein, mouse; C527924:Sox10 protein, mouse
keywords: Olig2; multiple sclerosis; oligodendrocyte; remyelination; tetracycline system